Background: Survey research is widely used for developing value-based management strategies in colorectal surgery. However, declining response rates threaten the validity of results. Our aim is to identify factors that influence response rate in colorectal surgical surveys and provide recommendations for future survey design.
Methods: We performed a (MEDLINE) search between 2007 and 2020 for survey studies in colorectal surgery providing response rates.
Results: Our search revealed 5693 studies, of which 128 studies were included. Patients with colorectal cancer have a lower mean response rate than patients with benign pathology (62.8% vs 75.5%, < 0.001). Response rate depends on the mode of survey; conducted in person (76%), postal (68%), email (61%) and web-based (44%). Patients participate more often than doctors ( < 0.001). Reminders can positively influence response rates in postal patient surveys ( = 0.03). The proportion of web-based doctor surveys has grown over time ( < 0.01) and overall survey response is declining over time ( = < 0.01).
Conclusion: In-person surveying should be explored first in colorectal surgery, especially when addressing colorectal cancer patients and doctors. Reminders are useful to boost response rate in postal surveys directed at patients. Web-based doctor surveys generate the lowest response rate. As response rate is declining, it is important to address these factors when designing and reviewing colorectal surgical survey studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749908 | PMC |
http://dx.doi.org/10.1016/j.sipas.2022.100068 | DOI Listing |
JAMA
January 2025
Department of General Surgery (Colorectal Surgery), Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Importance: Previous studies have demonstrated the advantages of short-term histopathological outcomes and complications associated with transanal total mesorectal excision (TME) compared with laparoscopic TME. However, the long-term oncological outcomes of transanal TME remain ambiguous. This study aims to compare 3-year disease-free survival of transanal TME with laparoscopic TME.
View Article and Find Full Text PDFAnn Surg Oncol
January 2025
Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol
January 2025
Department of Gastroenterology and Hepatology, Isala, Zwolle, The Netherlands.
Background: Similar to T1 colon cancer (CC), risk stratification may guide T2 CC treatment and reduce unnecessary major surgery. In this study, prediction models were developed that could identify T2 CC patients with a lower risk of lymph node metastasis (LNM) for whom (intensive) follow-up after local treatment could be considered.
Methods: A nationwide cohort study was performed involving pT2 CC patients who underwent surgery between 2012 and 2020, using data from the Dutch ColoRectal Audit, which were linked to the Nationwide Pathology Databank.
J Gastrointest Cancer
January 2025
The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, 110001, China.
Background: Colorectal cancer (CRC) stands as the third most prevalent malignancy globally and is recognized as the second leading cause of cancer-related mortality. Notably, nearly 50% of individuals diagnosed with CRC ultimately develop metastatic disease, with the peritoneum emerging as the second most frequent site for metastatic spread. Recent advancements in therapeutic frameworks have enhanced both survival rates and quality of life metrics for patients afflicted with colorectal cancer peritoneal metastases (CRCPM).
View Article and Find Full Text PDFCurr Treat Options Oncol
January 2025
The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Colorectal cancer is the third leading cause of cancer death worldwide. In China, the incidence and mortality of colorectal cancer are increasing, in which low rectal cancer is more common. Ultra-low rectal cancer refers to rectal cancer where the distance between the tumor and the anus is less than 5 cm, it accounts for about 70%-80% of rectal tumors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!